EP 2235537 A2 20101006 - IDENTIFICATION OF PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN HUMAN COLON CANCER
Title (en)
IDENTIFICATION OF PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN HUMAN COLON CANCER
Title (de)
IDENTIFIKATION VON MARKERN ZUR VORHERSAGE DER REAKTION AUF DASATINIB BEI MENSCHLICHEM DARMKREBS
Title (fr)
IDENTIFICATION DE MARQUEURS PRÉDICTIFS DE LA RÉPONSE AU DASATINIB DANS UN CANCER DU CÔLON HUMAIN
Publication
Application
Priority
- US 2009031860 W 20090123
- US 2379608 P 20080125
Abstract (en)
[origin: WO2009094556A2] Methods and compositions are provided useful in the diagnosis, treatment and management of cancers wherein cancer cells express certain polynucleotides and/or polypeptides that are differentially expressed in colon cancer subtypes that are sensitive to therapy with abl kinase inhibitors and src kinase inhibitors.
IPC 8 full level
G01N 33/574 (2006.01)
CPC (source: EP US)
A61P 35/00 (2017.12 - EP); C12Q 1/6886 (2013.01 - EP US); G01N 33/57496 (2013.01 - EP US); C12Q 2600/106 (2013.01 - EP US); C12Q 2600/158 (2013.01 - EP US); G01N 2333/91205 (2013.01 - EP US); G01N 2800/52 (2013.01 - EP US)
Citation (search report)
See references of WO 2009094556A2
Citation (examination)
HARDIMAN G: "MICROARRAY PLATFORMS - COMPARISONS AND CONTRASTS", PHARMACOGENOMICS, ASHLEY PUBLICATIONS, GB, vol. 5, no. 5, 1 January 2004 (2004-01-01), pages 487 - 502, XP009079995, ISSN: 1462-2416, DOI: 10.1517/14622416.5.5.487
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2009094556 A2 20090730; WO 2009094556 A3 20090911; EP 2235537 A2 20101006; US 2011166154 A1 20110707
DOCDB simple family (application)
US 2009031860 W 20090123; EP 09704105 A 20090123; US 86320709 A 20090123